October 2023

Revolutionizing Medical Education: College of Physicians and Surgeons Unveils Cutting-Edge Simulation Lab in India

newsmaker05 mins

The College of Physicians and Surgeons of Mumbai’s Simulation Lab The College of Physicians and Surgeons of Mumbai, an esteemed institution with a rich history spanning over a century, is proud to announce the inauguration of its state-of-the-art high fidelity Simulation Lab, the first-of-its-kind in Mumbai. This significant milestone underscores the institution’s ongoing commitment to…

Read More

Congrats, Charlesbank Capital Partners! Your Tech Opportunities Fund Takes Home the Gold for Best Performing Buyouts Fund Over $500 Million!

marketsgonewild04 mins

Hey there, readers! Let’s talk about awards, shall we? So, you know how sometimes you work really hard at something and then someone comes along and gives you an award for it? Well, that’s exactly what happened to Charlesbank Capital Partners’ Technology Opportunities Fund. The fund was recently recognized as a top performer in the…

Read More

Discover the Latest in Neurotechnology: Exciting Startups to Showcase at 2023 Neurotech Leaders Forum in San Francisco!

newscaster04 mins

Welcome to the 2023 Neurotech Leaders Forum! Exciting News in the Neurotechnology Industry I am thrilled to announce that the Neurotech Leaders Forum is set to take place in San Francisco on November 6-7. This event, organized by Neurotech Reports, will showcase several innovative neurotechnology startups and early-stage firms. As the most established event in…

Read More

Omniq Secures Multi-Year IoT Contract for Israel’s Largest and Newest Logistic Center: A Game-Changing Milestone

marketsgonewild04 mins

Omniq Secures Multi-Year IoT Contract for Israel’s Largest and Newest Logistic Center: A Game-Changing Milestone Description: New 463,000 sqft ultra-modern center is the largest and best equipped in Israel. Competitive win over several leading international logistic companies based on best-in-class service, equipment and reputation. SALT LAKE CITY, Oct. 31, 2023 (GLOBE NEWSWIRE) — OMNIQ Corp….

Read More

Unlocking Profitability: Omega Therapeutics Unveils Groundbreaking Preclinical Data on Epigenomic Control of CXCL Genes

NowTrending03 mins

Omega Therapeutics Presents New Preclinical Data Demonstrating Coordinated Modulation of Epigenetic Profile CAMBRIDGE, Mass., Oct. 31, 2023 (GLOBE NEWSWIRE) — The latest research from Omega Therapeutics showcases the coordinated modulation of the epigenetic profile of CXCL1-8 genes, resulting in the downregulation of gene expression and protein levels. This modulation has been shown to inhibit immune…

Read More

Revving Up for Success: The Three Wheeler Market Expected to Exceed $15.54 Billion by 2028 with a 10.7% CAGR Growth

marketinsights03 mins

The Growth of the Three-Wheeler Market A Bright Future Ahead As per a recent report by Allied Market Research, the global Three-Wheeler market is experiencing impressive growth. In 2020, the market was valued at $8.42 billion and is expected to reach $15.54 billion in the near future. This significant increase in value is a clear…

Read More

Breaking News: XOMA Hits $5 Million Milestone with FDA Approval of Tovorafenib for Pediatric Low-Grade Glioma Treatment

newsit04 mins

XOMA Earns $5 Million Milestone Upon FDA Acceptance of Day One’s Tovorafenib NDA for Relapsed or Progressive Pediatric Low-Grade Glioma EMERYVILLE, Calif., Oct. 31, 2023 (GLOBE NEWSWIRE) — XOMA Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today it has earned a $5 million milestone related to the U.S. Food and Drug Administration’s (FDA) acceptance…

Read More

Verve and Lilly Strengthen Partnership to Advance In Vivo Gene Editing Programs Targeting PCSK9 and ANGPTL3

newscaster04 mins

Verve and Lilly Relationship Expands to Include Verve’s In Vivo Gene Editing Program Lilly Purchases Product Rights to Verve’s Lead Cardiovascular Programs from Beam Therapeutics BOSTON, Oct. 31, 2023 (GLOBE NEWSWIRE) Verve Therapeutics, Inc., a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene editing medicines, today announced…

Read More